AIM
AMED

Advantage Investment Management’s Amedisys AMED Stock Holding History

Advantage Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$51K Hold
389
– – 0.04% 332
2019
Q2 		$47K Hold
389
– – 0.04% 355
2019
Q1 		$48K Buy
+389
New +$48.8K 0.04% 352

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Advantage Investment Management's AMED Position: Q3 2019 in Review

Advantage Investment Management held its Amedisys (AMED) position steady in Q3 2019 at 389 shares worth $51K. The position accounts for 0.04% of the portfolio, ranked #332.

Advantage Investment Management first reported a position in AMED in Q1 2019 and has held it in 3 quarters since. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

  • Advantage Investment Management held 389 shares of Amedisys worth $51K as of Q3 2019.
  • Advantage Investment Management left its Amedisys share count unchanged in Q3 2019.
  • Amedisys made up 0.04% of Advantage Investment Management's portfolio in Q3 2019, its #332 holding.
  • Advantage Investment Management first reported a position in Amedisys in Q1 2019 and has held it in 3 quarters since.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.